New York State Common Retirement Fund
ANTX icon

New York State Common Retirement Fund’s AN2 Therapeutics ANTX Stock Holding History

New York State Common Retirement Fund’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2K Buy
+5,000
New +$21.5K ﹤0.01% 3107
2023
Q3 		– Sell
-101
Closed -$859 – 3271
2023
Q2 		$859 Sell
101
-5,778
-98% -$41.5K ﹤0.01% 3324
2023
Q1 		$58K Buy
5,879
+54
+0.9% +$600 ﹤0.01% 2955
2022
Q4 		$55.5K Hold
5,825
– – ﹤0.01% 3074
2022
Q3 		$101K Sell
5,825
-5,575
-49% -$65K ﹤0.01% 3008
2022
Q2 		$88K Buy
+11,400
New +$151K ﹤0.01% 3113

Other funds holding ANTX

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

New York State Common Retirement Fund's ANTX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in AN2 Therapeutics (ANTX) in Q2 2026: 5,000 shares worth $24.2K. The stake represents ﹤0.01% of the portfolio and ranks #3107 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in ANTX as recently as Q2 2023.

New York State Common Retirement Fund first reported a position in ANTX in Q2 2022 and has held it in 6 quarters since. The position peaked at $101K in Q3 2022. 66 funds tracked by Wall St. Rank hold ANTX as of Q2 2026.

  • New York State Common Retirement Fund held 5,000 shares of AN2 Therapeutics worth $24.2K as of Q2 2026.
  • AN2 Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • AN2 Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3107 holding.
  • New York State Common Retirement Fund first reported a position in AN2 Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • New York State Common Retirement Fund's AN2 Therapeutics position peaked at $101K in Q3 2022.
  • 66 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.